KBC Group’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$41.3M Buy
632,833
+170,416
+37% +$12.7M 0.1% 177
2025
Q4
$36.6M Buy
462,417
+158,242
+52% +$12.1M 0.08% 191
2025
Q3
$22.2M Sell
304,175
-32,707
-10% -$2.4M 0.05% 256
2025
Q2
$25.5M Buy
336,882
+44,062
+15% +$3.12M 0.07% 245
2025
Q1
$22.3M Buy
292,820
+57,887
+25% +$4.31M 0.07% 261
2024
Q4
$15.5M Buy
234,933
+206,466
+725% +$14.5M 0.04% 314
2024
Q3
$1.99M Sell
28,467
-2,112
-7% -$127K 0.01% 617
2024
Q2
$1.62M Buy
+30,579
New +$1.86M ﹤0.01% 616

Other funds holding SOLV

KBC Group's SOLV Position: Q1 2026 in Review

KBC Group increased its Solventum (SOLV) stake by 37% in Q1 2026, buying an estimated $12.7M and bringing the position to 632,833 shares worth $41.3M. The position accounts for 0.1% of the portfolio, ranked #177.

KBC Group first reported a position in SOLV in Q2 2024 and has held it in 8 quarters since. 879 funds tracked by Wall St. Rank hold SOLV as of Q1 2026.

  • KBC Group held 632,833 shares of Solventum worth $41.3M as of Q1 2026.
  • KBC Group bought 170,416 Solventum shares in Q1 2026, an estimated $12.7M.
  • Solventum made up 0.1% of KBC Group's portfolio in Q1 2026, its #177 holding.
  • KBC Group first reported a position in Solventum in Q2 2024 and has held it in 8 quarters since.
  • 879 funds tracked by Wall St. Rank held Solventum as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.